Federico Baldi
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
-
- Antibiotic Use and Resistance
Papers in
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
- HIV/AIDS Research and Interventions 1
- Viral Infections and Vectors 1
-
- Long-Term Effects of COVID-19 2
- Co-authors
- Chiara Dentone (4 shared papers)Daniele Roberto Giacobbe (3 shared papers)Matteo Bassetti (4 shared papers)Małgorzata Mikulska (2 shared papers)Laura Magnasco (2 shared papers)Michele Mirabella (2 shared papers)Chiara Sepulcri (3 shared papers)Laura Labate (2 shared papers)
- Journals
- Clinical Infectious Diseases (1 paper)AIDS (1 paper)Emerging infectious diseases (1 paper)Annals of Medicine (1 paper)Frontiers in Medicine (1 paper)
- Partner nations
- ItalySpainUnited States
In The Last Decade
Federico Baldi
4 papers receiving 118 citations
Federico Baldi's Hit Papers
Peers
Comparison fields: 5 of 37
- Infectious Diseases 101
- Applied Microbiology and Biotechnology 9
- Neurology 37
- Clinical Biochemistry 7
- Oncology 22
Countries citing papers authored by Federico Baldi
This map shows the geographic impact of Federico Baldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Baldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Baldi more than expected).
Fields of papers citing papers by Federico Baldi
This network shows the impact of papers produced by Federico Baldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Baldi. The network helps show where Federico Baldi may publish in the future.
Co-authors
The 25 scholars most cited alongside Federico Baldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients Hit paper breakdown → | 2023 | 71 |
| 2 | 2021 | 27 | |
| 3 | 2023 | 20 | |
| 4 | 2024 | 1 | |
| 5 | 2025 | 0 |
About Federico Baldi
Federico Baldi is a scholar working on Infectious Diseases, Neurology, Epidemiology, Virology and Ecology, Evolution, Behavior and Systematics, having authored 5 papers that have together received 119 indexed citations. Recurring topics across this work include Long-Term Effects of COVID-19 (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers), HIV Research and Treatment (1 paper), HIV, Drug Use, Sexual Risk (1 paper), HIV/AIDS Research and Interventions (1 paper), Vector-borne infectious diseases (1 paper) and Viral Infections and Vectors (1 paper). The work is most often cited by research in Infectious Diseases (101 citations), Applied Microbiology and Biotechnology (9 citations), Neurology (37 citations), Clinical Biochemistry (7 citations) and Oncology (22 citations). Federico Baldi has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Chiara Dentone, Daniele Roberto Giacobbe, Matteo Bassetti, Małgorzata Mikulska, Laura Magnasco, Michele Mirabella, Chiara Sepulcri, Laura Labate, Federica Magnè and Chiara Russo. Their work appears in journals such as Clinical Infectious Diseases, AIDS, Emerging infectious diseases, Annals of Medicine and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.